Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

JAZZ

Jazz Pharmaceuticals plc

Jun 18 • 04:00PM ET

224.66

-2.27 -1.00 %

Healthcare • Biotechnology • Ireland • Large • NASD

Jun 17, 7:05 AMJazz, AbCellera sign preclinical T‑cell multispecific antibody deal for GI and other solid tumors with $56M upfront, up to $792M per program

Peers: ALNY BMRN EXEL INCY NBIX IONS RPRX VRTX LGND ASND

| Held by: IJH VTI VB VBR VXF MDY IJK SPMD COWG CALF

Index	-	P/E	-	EPS (ttm)	-0.02	Insider Own	4.57%	Shs Outstand	62.70M	Perf Week	-4.87%
Market Cap	14.11B	Forward P/E	8.72	EPS next Y	25.75	Insider Trans	-3.60%	Shs Float	59.95M	Perf Month	-5.39%
Enterprise Value	16.66B	PEG	0.17	EPS next Q	6.18	Inst Own	104.16%	Short Float	7.16%	Perf Quarter	23.58%
Income	29.49M	P/S	3.18	EPS this Y	202.69%	Inst Trans	5.60%	Short Ratio	4.66	Perf Half Y	32.36%
Sales	4.44B	P/B	3.11	EPS next Y	1.52%	ROA	0.25%	Short Interest	4.29M	Perf YTD	32.15%
Book/sh	72.29	P/C	4.91	EPS next 5Y	52.40%	ROE	0.68%	52W High	243.32 -7.67%	Perf Year	107.56%
Cash/sh	45.76	P/FCF	11.12	EPS past 3/5Y	-17.69% -	ROIC	0.33%	52W Low	105.00 113.96%	Perf 3Y	74.56%
Dividend Est.	-	EV/EBITDA	10.67	Sales past 3/5Y	5.26% 12.54%	Gross Margin	72.85%	Volatility	2.46% 2.84%	Perf 5Y	26.73%
Dividend TTM	-	EV/Sales	3.75	EPS Y/Y TTM	-94.01%	Oper. Margin	19.12%	ATR (14)	6.65	Perf 10Y	56.42%
Dividend Ex-Date	-	Quick Ratio	1.85	Sales Y/Y TTM	9.20%	Profit Margin	0.66%	RSI (14)	45.78	Recom	1.57
Dividend Gr. 3/5Y	- -	Current Ratio	2.04	EPS Q/Q	392.19%	SMA20	-3.60%	Beta	0.34	Target Price	260.39
Payout	-	Debt/Eq	1.20	Sales Q/Q	19.05%	SMA50	2.00%	Rel Volume	2.07	Prev Close	226.93
Employees	2890	LT Debt/Eq	0.96	Earnings	May 05 AMC	SMA200	28.34%	Avg Volume	920.20K	Price	224.66
IPO	Jun 01, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	36.60% 9.22%	Trades		Volume	1,906,833	Change	-1.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-09-26	Resumed	Truist	Buy	$256
May-22-26	Initiated	Bernstein	Mkt Perform	$229
May-19-26	Upgrade	UBS	Neutral → Buy	$307
Apr-10-26	Resumed	Raymond James	Outperform	$227
Feb-27-26	Initiated	Barclays	Overweight	$224
Nov-24-25	Downgrade	UBS	Buy → Neutral	$188
Jul-15-25	Initiated	Deutsche Bank	Buy	$152
Mar-07-25	Upgrade	UBS	Neutral → Buy	$145 → $179
Feb-26-25	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Feb-13-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$130 → $170
Dec-12-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$140 → $175
Jun-05-24	Initiated	Goldman	Buy	$169
Jan-03-24	Initiated	Robert W. Baird	Outperform	$160
Nov-27-23	Downgrade	UBS	Buy → Neutral	$170 → $135
Sep-29-23	Initiated	Raymond James	Mkt Perform
Jun-12-23	Resumed	Wells Fargo	Equal Weight	$184 → $140
Dec-09-22	Upgrade	Goldman	Neutral → Buy	$192 → $190
Jun-14-22	Initiated	UBS	Buy	$194
Apr-06-22	Downgrade	Goldman	Buy → Neutral	$202 → $196
Nov-19-21	Resumed	Goldman	Buy	$198

Show Previous Ratings

Jun-18-26 06:33AM	Jazz and AbCellera sign deal for T-cell engagers in solid tumours (Pharmaceutical Technology)
Jun-17-26 08:50AM	Jazz Pharmaceuticals and AbCellera Partner on Antibody Programs for Solid Tumors (InvestorsHub)
07:00AM	Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies (PR Newswire)
Jun-16-26 04:05PM	Jazz Pharmaceuticals Delivers Extensive Late-Breaking Data at SLEEP 2026, Demonstrating Real-World Impact of Xywav (calcium, magnesium, potassium, and sodium oxybates) on Patient Outcomes Across Narcolepsy and Idiopathic Hypersomnia (PR Newswire)
Jun-12-26 08:00AM	Jazz Pharmaceuticals Provides Update on Zepzelca (lurbinectedin) Phase 3 LAGOON Trial in Second-Line Small Cell Lung Cancer (PR Newswire)
07:45AM	Loading…
Jun-04-26 07:45AM	Jazz Pharmaceuticals to Present Comprehensive Data at SLEEP 2026 Highlighting Broad Treatment Effects of Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for People with Narcolepsy and Idiopathic Hypersomnia (PR Newswire)
May-28-26 04:27PM	JPMorgan says large-cap biotech is back as profits and pipelines fuel upside (Investing.com)
May-27-26 05:00PM	Phase 3 HERIZON-GEA-01 Results Published in The New England Journal of Medicine Show Durable and Consistent Survival Benefit with Ziihera (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA (PR Newswire)
May-22-26 09:38AM	Texas Instruments, Generac upgraded: Wall Street's top analyst calls (The Fly)
May-19-26 09:34AM	StubHub, Jazz Pharmaceuticals upgraded: Wall Street's top analyst calls (The Fly)
May-12-26 04:15PM	Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences (PR Newswire)
May-06-26 08:30AM	Jazz Pharmaceuticals plc Q1 2026 Earnings Call Summary (Moby) +7.68%
May-05-26 04:31PM	Jazz: Q1 Earnings Snapshot (Associated Press)
04:05PM	Jazz Pharmaceuticals Announces First Quarter 2026 Financial Results (PR Newswire)
Apr-27-26 07:45AM	Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental Biologics License Application for Ziihera (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA (PR Newswire)
04:15PM	Loading…
Apr-21-26 04:15PM	Jazz Pharmaceuticals to Report First Quarter Financial Results on May 5, 2026 (PR Newswire)
04:05PM	Jazz Pharmaceuticals to Present Data at ASCO 2026 Highlighting Advancements for Ziihera (zanidatamab-hrii) in Gastroesophageal Adenocarcinoma and Zepzelca (lurbinectedin) (PR Newswire)
Apr-10-26 09:37AM	Nike downgraded, IBM initiated: Wall Street's top analyst calls (The Fly)
Apr-09-26 07:45AM	Jazz Pharmaceuticals to Present Research on Epidiolex (cannabidiol) and Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution at the 2026 American Academy of Neurology Annual Meeting (PR Newswire)
Apr-01-26 04:15PM	Jazz Pharmaceuticals to Participate in Needham Virtual Healthcare Conference (PR Newswire)
Mar-24-26 01:49PM	American Nutrition Association Announces Initiative with Jazz Pharmaceuticals to Advance Evidence-Based Sodium Reduction and Cardiovascular Health Education (PR Newswire)
Mar-18-26 07:44AM	Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing Oncology Research at AACR 2026 (PR Newswire)
Mar-09-26 11:40AM	JAZZ or ACAD: Which Is the Better Value Stock Right Now? (Zacks)
Mar-06-26 03:17PM	Taco Bell Parent, Data Center Play And Two Other Stocks Weather War Storm, Hover Near Highs (Investor's Business Daily)
Mar-05-26 08:02PM	Saniona AB (FRA:30S) Q4 2025 Earnings Call Highlights: Strategic Partnerships and Financial ... (GuruFocus.com)
Mar-03-26 03:24PM	Jazz Pharmaceuticals plc (JAZZ) Reports $1.2 Billion Q4 Revenue, Beats $1.17B Estimate (Insider Monkey)
Mar-02-26 10:37AM	Zymeworks Q4 Earnings Call Highlights (MarketBeat)
09:15AM	Jazz (JAZZ) Reliance on International Sales: What Investors Need to Know (Zacks)
Mar-01-26 04:27AM	Is Jazz Pharmaceuticals (JAZZ) One of the Best Cheap Biotech Stocks to Buy Now? (Insider Monkey)
Feb-27-26 09:54AM	Jazz Pharmaceuticals' CBD Drug Hits $1B: Time to Buy the Stock? (Zacks)
08:51AM	Loading…
08:51AM	Jazz Pharmaceuticals plc (JAZZ) Jumps Nearly 30% on Strong Q3 and Cancer Drug Trial Progress (Insider Monkey)
07:59AM	Here Are Fridays Top Wall Street Analyst Research Calls: Block, Costco, Dollar Tree, Duolingo, Palantir Technologies, Southwest Airlines, Synopsis, Warner Bros. Discovery, and More (24/7 Wall St.)
Feb-26-26 07:55AM	Company News for Feb 26, 2026 (Zacks)
Feb-25-26 07:55PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research) +13.23%
03:51PM	Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why (StockStory)
12:49PM	Stock Market Today: Nasdaq, Dow Hold Gains Before Nvidia Earnings; Vertiv, Keysight Advance (Live Coverage) (Investor's Business Daily)
11:19AM	Stock Market Today: Dow Advance Melts Before Nvidia Earnings; Missile Firm L3Harris Eyes Entry (Live Coverage) (Investor's Business Daily)
10:56AM	JAZZ Stock Rises as Q4 Earnings & Sales Top Expectations (Zacks)
10:24AM	Stock Market Today: Dow Up 100 Points Before Nvidia Earnings; This Drug Firm Breaks Out (Live Coverage) (Investor's Business Daily)
08:30AM	Jazz Pharmaceuticals plc Q4 2025 Earnings Call Summary (Moby)
12:08AM	Jazz Pharmaceuticals Q4 Earnings Call Highlights (MarketBeat)
12:04AM	Jazz Pharmaceuticals PLC (JAZZ) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
Feb-24-26 08:00PM	Jazz (JAZZ) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
07:30PM	Jazz Pharmaceuticals (JAZZ) Beats Q4 Earnings and Revenue Estimates (Zacks)
04:30PM	Jazz: Q4 Earnings Snapshot (Associated Press Finance)
04:20PM	Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q4 CY2025 Sales (StockStory)
12:08PM	AXSM Q4 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales (Zacks)
Feb-23-26 07:03PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
Feb-22-26 10:10PM	Jazz Pharmaceuticals Earnings: What To Look For From JAZZ (StockStory)
Feb-19-26 09:15AM	What Analyst Projections for Key Metrics Reveal About Jazz (JAZZ) Q4 Earnings (Zacks)
Feb-18-26 10:00AM	Arcutis Biotherapeutics, Inc. (ARQT) Earnings Expected to Grow: Should You Buy? (Zacks)
08:36AM	Ovintiv to Report Q4 Earnings: What's in Store for the Stock? (Zacks)
Feb-17-26 04:15PM	Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences (PR Newswire)
10:00AM	Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Feb-11-26 08:36AM	Is the Options Market Predicting a Spike in Jazz Pharmaceuticals Stock? (Zacks)
Feb-10-26 04:15PM	Jazz Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Tuesday, February 24, 2026 (PR Newswire)
Feb-09-26 07:51AM	Moderna to Report Q4 Earnings: Is a Beat in Store for the Stock? (Zacks)
Feb-03-26 07:56AM	New Drugs Take Center Stage as Biogen Heads Into Q4 Earnings (Zacks)
06:55AM	Truist Securities Raises Jazz Pharmaceuticals (JAZZ) Price Target After HERIZON-GEA Trial (Insider Monkey)
Jan-30-26 12:39PM	This Pharma Stock Eyes Entries, Battles For Key Level Amid 68% Earnings Growth (Investor's Business Daily)
Jan-27-26 12:22PM	Harmony Biosciences' Sales and Profits Have Soared. Why Hasn't Its Stock Followed? (Motley Fool)
Jan-26-26 10:15AM	Auvelity Continues to Aid AXSM's Top Line: More Upside in 2026? (Zacks)
Jan-16-26 06:24AM	Wegovy pill off to a fast start; Ex-Emergent CEO sued for insider trading (BioPharma Dive)
Jan-15-26 12:41PM	JPM26: Jazz sells PRV for $200m, targets deals in 2026 (Pharmaceutical Technology)
Jan-13-26 07:43AM	Jazz Pharmaceuticals price target raised to $235 from $210 at Needham (TipRanks)
Jan-09-26 12:19PM	Jazz Pharmaceuticals touts Phase 3 zanidatamab OS win in HER2+ GEA, eyes FDA sBLA in H1 (MarketBeat)
Jan-08-26 07:50PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research) -5.38%
04:05PM	Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer (PR Newswire)
Jan-06-26 01:32PM	Ziihera (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA Including More Than Two Years Median Overall Survival Benefit (PR Newswire)
Dec-28-25 10:37PM	Reflecting On Pharmaceuticals Stocks' Q3 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ) (StockStory)
Dec-17-25 11:03PM	3 Reasons JAZZ is Risky and 1 Stock to Buy Instead (StockStory)
04:15PM	Jazz Pharmaceuticals to Participate in Upcoming Investor Events (PR Newswire)
Dec-05-25 11:30AM	Jazz (JAZZ) Up 24.5% Since Last Earnings Report: Can It Continue? (Zacks)
09:00AM	Jazz Pharmaceuticals to Present Extensive New Data and Real-World Evidence Highlighting Epidiolex (cannabidiol) Outcomes in Treatment-Resistant Epilepsies at the American Epilepsy Society 2025 Annual Meeting (PR Newswire)
07:12AM	Trials, Sales Wins Sends Jazz Pharmaceuticals Higher (FX Empire)
Dec-02-25 04:05PM	Jazz Pharmaceuticals to Present Pivotal Phase 3 Results of Ziihera (zanidatamab-hrii) Combinations in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma at the 2026 ASCO Gastrointestinal Cancers Symposium (PR Newswire)
Nov-26-25 09:13AM	Why Jazz Pharmaceuticals May Be a Stealth Cannabis Winner (Zacks)
Nov-24-25 09:41AM	Booking, Carvana upgraded: Wall Street's top analyst calls (The Fly)
09:20AM	Here are Mondays Top Wall Street Analyst Research Calls: Baidu, Carvana, Exact Sciences, Ferrari, Marvell Technology, Meta Platforms and More (24/7 Wall St.)
Nov-20-25 01:37AM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
Nov-18-25 04:15PM	Jazz Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference (PR Newswire) +6.13%
12:16PM	JAZZ Hits 52-Week High on Encouraging Gastric Cancer Study Data (Zacks)
03:38AM	Zymeworks to change course, pursue royalty-driven biotech model (BioPharma Dive)
12:43AM	Jazz Pharma (JAZZ) Hits Fresh 52-Week High on Strong Cancer Treatment Trial (Insider Monkey)
Nov-17-25 07:29PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research) +20.57%
04:44PM	Jazz, Zymeworks Catapult On Their 'Sweeping Success' In Gastric Cancer (Investor's Business Daily)
04:13PM	Stocks to Watch Recap: Alphabet, Tesla, Netflix, Zymeworks (The Wall Street Journal)
11:41AM	Why Is Jazz Pharmaceuticals (JAZZ) Stock Soaring Today (StockStory)
09:35AM	Stocks to Watch Monday: Alphabet, Tesla, Netflix, Zymeworks (The Wall Street Journal)
09:15AM	Why Jazz (JAZZ) International Revenue Trends Deserve Your Attention (Zacks)
08:10AM	Jazz Pharmaceuticals and Zymeworks Report Positive Cancer Treatment Results. The Stocks Soar. (Barrons.com)
06:00AM	Positive HERIZON-GEA-01 Phase 3 Results Support Ziihera (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and Ziihera Combination Regimens as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma (PR Newswire)
Nov-12-25 12:36AM	The Top 5 Analyst Questions From Jazz Pharmaceuticals's Q3 Earnings Call (StockStory)
Nov-11-25 07:45AM	Jazz Pharmaceuticals Showcases New Clinical and Translational Data for Modeyso (dordaviprone) in H3 K27M-mutant Diffuse Midline Glioma at SNO 2025 (PR Newswire)
Nov-06-25 10:50AM	JAZZ Beats on Q3 Earnings & Sales, Narrows '25 Sales View (Zacks)
12:33AM	JAZZ Q3 Deep Dive: New Drug Launches and Portfolio Expansion Drive Strong Results (StockStory)
12:01AM	Jazz Pharmaceuticals PLC (JAZZ) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
Nov-05-25 07:00PM	Jazz (JAZZ) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:35PM	Jazz Pharmaceuticals (JAZZ) Q3 Earnings and Revenues Beat Estimates (Zacks)
04:32PM	Jazz: Q3 Earnings Snapshot (Associated Press Finance)

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Co-Founder & ChairmanMr. Bruce C. Cozadd

PresidentMs. Renee D. Gala

Executive VP & CFOMr. Philip L. Johnson

Executive VP & Chief Legal OfficerMs. Neena M. Patil J.D.

Executive VPDr. Robert Iannone M.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Smith Mark Douglas	Director	Jun 15 '26	Sale	230.55	1,157	266,746	9,680	Jun 17 04:45 PM
MARK D SMITH	Director	Jun 15 '26	Proposed Sale	230.55	1,157	266,746		Jun 15 04:09 PM
Patil Neena M	EVP & Chief Legal Officer	Jun 10 '26	Sale	231.83	1,200	278,196	51,549	Jun 12 04:14 PM
NEENA PATIL	Officer	Jun 10 '26	Proposed Sale	231.83	1,200	278,196		Jun 10 04:04 PM
COZADD BRUCE C	Director	Jun 01 '26	Sale	235.12	6,000	1,410,720	372,682	Jun 03 05:09 PM
Bruce C Cozadd	Officer	Jun 01 '26	Proposed Sale	235.12	6,000	1,410,720		Jun 01 04:13 PM
Patil Neena M	EVP & Chief Legal Officer	May 28 '26	Sale	236.97	1,192	282,468	52,626	Jun 01 04:09 PM
Pearce Samantha	EVP, Chief Commercial Officer	May 28 '26	Option Exercise	109.45	6,907	755,971	57,179	Jun 01 04:06 PM
Pearce Samantha	EVP, Chief Commercial Officer	May 28 '26	Sale	235.41	6,907	1,625,977	50,272	Jun 01 04:06 PM
Mulligan Seamus	Director	May 28 '26	Option Exercise	138.08	3,415	471,543	1,183,028	Jun 01 04:01 PM
NEENA PATIL	Officer	May 28 '26	Proposed Sale	236.97	1,192	282,468		May 28 04:21 PM
SAMANTHA PEARCE	Officer	May 28 '26	Proposed Sale	235.41	6,907	1,625,977		May 28 04:18 PM
Winningham Rick E	Director	May 22 '26	Option Exercise	138.08	3,415	471,543	12,308	May 27 06:13 PM
Winningham Rick E	Director	May 22 '26	Sale	241.57	2,741	662,143	9,567	May 27 06:13 PM
McSharry Heather Ann	Director	May 22 '26	Sale	241.00	2,000	482,000	18,449	May 27 06:07 PM
HEATHER MCSHARRY	Director	May 22 '26	Proposed Sale	241.00	2,000	482,000		May 22 04:27 PM
RICK WINNINGHAM	Director	May 22 '26	Proposed Sale	241.57	2,741	662,143		May 22 04:13 PM
COZADD BRUCE C	Director	May 01 '26	Sale	203.33	6,000	1,219,980	378,682	May 05 04:27 PM
Bruce C Cozadd	Officer	May 01 '26	Proposed Sale	203.33	6,000	1,219,980		May 01 03:44 PM
COZADD BRUCE C	Director	Apr 01 '26	Sale	190.50	6,000	1,143,010	384,682	Apr 03 05:09 PM
Bruce C Cozadd	Officer	Apr 01 '26	Proposed Sale	190.50	6,000	1,143,010		Apr 01 04:03 PM
Carr Patricia	SVP, Chief Accounting Officer	Mar 09 '26	Sale	182.94	1,287	235,444	6,512	Mar 09 05:15 PM
PATRICIA CARR	Officer	Mar 09 '26	Proposed Sale	182.94	1,287	235,444		Mar 09 04:26 PM
Carr Patricia	Officer	Mar 05 '26	Proposed Sale	188.69	2,723	513,803		Mar 05 02:48 PM
Henderson Mary Elizabeth	Officer	Feb 26 '26	Proposed Sale	188.69	2,643	498,708		Mar 05 01:58 PM
COZADD BRUCE C	Director	Mar 03 '26	Sale	186.44	6,000	1,118,613	405,796	Mar 04 04:24 PM
Bruce C Cozadd	Officer	Mar 03 '26	Proposed Sale	186.44	6,000	1,118,613		Mar 03 02:35 PM
RIEDEL NORBERT G	Director	Feb 27 '26	Option Exercise	138.08	3,415	471,543	10,439	Mar 02 05:36 PM
RIEDEL NORBERT G	Director	Feb 27 '26	Sale	192.00	3,415	655,680	7,024	Mar 02 05:36 PM
Carr Patricia	SVP, Chief Accounting Officer	Feb 26 '26	Sale	194.11	1,253	243,222	10,352	Mar 02 05:14 PM
Carr Patricia	SVP, Chief Accounting Officer	Feb 27 '26	Sale	190.91	1,117	213,243	9,235	Mar 02 05:14 PM
Patil Neena M	EVP & Chief Legal Officer	Feb 26 '26	Option Exercise	127.23	51,000	6,488,700	83,946	Mar 02 05:06 PM
Patil Neena M	EVP & Chief Legal Officer	Feb 26 '26	Sale	191.56	55,600	10,650,482	56,862	Mar 02 05:06 PM
Henderson Mary Elizabeth	SVP, Technical Operations	Feb 26 '26	Sale	194.49	5,343	1,039,134	28,728	Mar 02 05:04 PM
PATRICIA CARR	Officer	Feb 27 '26	Proposed Sale	190.91	1,117	213,243		Feb 27 04:22 PM
NORBERT RIEDEL	Director	Feb 27 '26	Proposed Sale	192.00	3,415	655,680		Feb 27 04:12 PM
NEENA PATIL	Officer	Feb 26 '26	Proposed Sale	191.56	55,600	10,650,480		Feb 26 04:14 PM
Carr Patricia	Officer	Feb 26 '26	Proposed Sale	196.83	2,370	466,487		Feb 26 04:08 PM
Henderson Mary Elizabeth	Officer	Feb 26 '26	Proposed Sale	196.83	10,116	1,991,132		Feb 26 03:48 PM
Henderson Mary Elizabeth	SVP, Technical Operations	Dec 09 '25	Sale	169.51	2,238	379,366	19,508	Dec 11 05:19 PM
MARY ELIZABETH HENDERSON	Officer	Dec 09 '25	Proposed Sale	169.51	2,238	379,365		Dec 09 06:52 PM
Carr Patricia	SVP, Chief Accounting Officer	Dec 05 '25	Option Exercise	140.67	4,500	633,015	11,512	Dec 09 05:25 PM
Carr Patricia	SVP, Chief Accounting Officer	Dec 05 '25	Sale	171.20	4,660	797,783	7,012	Dec 09 05:25 PM
PATRICIA CARR	Officer	Dec 05 '25	Proposed Sale	171.20	4,660	797,783		Dec 05 04:03 PM
O'Keefe Kenneth W	Director	Dec 02 '25	Proposed Sale	176.59	1,249	220,561		Dec 01 08:55 PM
COZADD BRUCE C	Director	Nov 26 '25	Option Exercise	123.36	77,500	9,560,400	470,832	Dec 01 06:14 PM
COZADD BRUCE C	Director	Nov 26 '25	Sale	177.81	77,500	13,780,337	393,332	Dec 01 06:14 PM
BRUCE COZADD	Director	Nov 26 '25	Proposed Sale	177.81	77,500	13,780,337		Nov 26 05:37 PM
McSharry Heather Ann	Director	Nov 20 '25	Option Exercise	138.08	3,415	471,543	23,864	Nov 24 05:47 PM
McSharry Heather Ann	Director	Nov 20 '25	Sale	177.78	3,415	607,127	20,449	Nov 24 05:47 PM
COZADD BRUCE C	Director	Nov 18 '25	Sale	181.09	18,000	3,259,538	390,826	Nov 20 08:03 PM
Carr Patricia	SVP, Chief Accounting Officer	Nov 18 '25	Option Exercise	136.18	5,250	714,945	12,262	Nov 20 06:13 PM
Carr Patricia	SVP, Chief Accounting Officer	Nov 18 '25	Sale	182.06	5,319	968,402	7,012	Nov 20 06:13 PM
Winningham Rick E	Director	Nov 18 '25	Sale	180.86	5,500	994,728	8,893	Nov 20 05:54 PM
HEATHER MCSHARRY	Director	Nov 20 '25	Proposed Sale	177.78	3,415	607,127		Nov 20 04:05 PM
Henderson Mary Elizabeth	Officer	Nov 19 '25	Proposed Sale	127.23	2,961	376,740		Nov 19 08:59 PM
Iannone Robert	EVP, Global Head of R&D & CMO	Nov 17 '25	Sale	168.26	7,159	1,204,573	72,628	Nov 19 08:31 PM
Bruce C Cozadd	Officer	Nov 18 '25	Proposed Sale	181.09	18,000	3,259,537		Nov 18 07:08 PM
RICK WINNINGHAM	Director	Nov 18 '25	Proposed Sale	180.86	5,500	994,728		Nov 18 05:20 PM
PATRICIA CARR	Officer	Nov 18 '25	Proposed Sale	182.06	5,319	968,402		Nov 18 04:59 PM
ROBERT IANNONE	Officer	Nov 17 '25	Proposed Sale	168.26	7,159	1,204,573		Nov 17 04:06 PM
COZADD BRUCE C	Director	Oct 03 '25	Sale	140.00	3,500	490,000	408,826	Oct 03 09:27 PM
COZADD BRUCE C	Director	Oct 01 '25	Sale	131.78	2,000	263,560	412,326	Oct 03 09:27 PM
Bruce C Cozadd	Officer	Oct 03 '25	Proposed Sale	140.00	3,500	490,000		Oct 03 04:10 PM
COZADD BRUCE C	Director	Sep 02 '25	Sale	128.62	6,000	771,690	429,973	Sep 04 05:48 PM
Winningham Rick E	Director	Aug 08 '25	Proposed Sale	112.00	3,731	417,872		Aug 08 03:02 PM
Kennedy Patrick	Director	Aug 08 '25	Proposed Sale	112.00	3,731	417,872		Aug 08 02:56 PM
ENRIGHT PATRICK G	Director	Aug 08 '25	Proposed Sale	112.00	3,731	417,872		Aug 08 02:46 PM
RIEDEL NORBERT G	Director	Aug 08 '25	Proposed Sale	112.00	3,731	417,872		Aug 08 02:40 PM
Smith Mark Douglas	Director	Aug 08 '25	Proposed Sale	112.00	3,731	417,872		Aug 08 02:33 PM
Hamill Laura	Director	Aug 08 '25	Proposed Sale	112.00	3,731	417,872		Aug 08 02:26 PM
O'Keefe Kenneth W	Director	Aug 08 '25	Proposed Sale	112.00	3,731	417,872		Aug 08 02:20 PM
Cook Jennifer E.	Director	Aug 08 '25	Proposed Sale	112.00	3,731	417,872		Aug 08 02:13 PM
McSharry Heather Ann	Director	Aug 08 '25	Proposed Sale	112.00	3,731	417,872		Aug 08 02:06 PM
ORiordan Anne	Director	Aug 08 '25	Proposed Sale	112.00	3,731	417,872		Aug 08 02:00 PM
COZADD BRUCE C	Chairman & CEO	Aug 01 '25	Sale	113.21	1,000	113,210	435,973	Aug 05 04:54 PM
COZADD BRUCE C	Officer	Aug 01 '25	Proposed Sale	121.80	9,000	1,096,210		Aug 01 03:28 PM
COZADD BRUCE C	Chairman & CEO	Jul 01 '25	Sale	107.63	1,000	107,630	436,973	Jul 03 02:56 PM
COZADD BRUCE C	Officer	Jul 01 '25	Proposed Sale	107.63	1,000	107,630		Jul 01 04:15 PM

Open in Screener

PHR

Phreesia Inc

Jun 18 • 04:00PM ET

9.38

+0.03 0.32 %

Healthcare • Health Information Services • USA • Small • NYSE

Peers: HSTM DOCS EVH HCAT OMCL TDOC VEEV CERT SDGR HIMS

| Held by: VTI IWM VXF IWO FESM VTWO SCHA SFLO PSC VHT

Index	RUT	P/E	63.04	EPS (ttm)	0.15	Insider Own	19.49%	Shs Outstand	61.77M	Perf Week	3.65%
Market Cap	579.80M	Forward P/E	14.48	EPS next Y	0.65	Insider Trans	29.51%	Shs Float	49.77M	Perf Month	2.29%
Enterprise Value	597.65M	PEG	0.09	EPS next Q	0.09	Inst Own	82.90%	Short Float	6.74%	Perf Quarter	-20.31%
Income	9.18M	P/S	1.17	EPS this Y	902.56%	Inst Trans	-10.69%	Short Ratio	1.71	Perf Half Y	-42.63%
Sales	495.59M	P/B	1.61	EPS next Y	61.50%	ROA	1.72%	Short Interest	3.35M	Perf YTD	-44.56%
Book/sh	5.81	P/C	7.76	EPS next 5Y	168.43%	ROE	2.86%	52W High	32.76 -71.37%	Perf Year	-63.45%
Cash/sh	1.21	P/FCF	8.22	EPS past 3/5Y	- -	ROIC	2.06%	52W Low	7.77 20.72%	Perf 3Y	-70.49%
Dividend Est.	-	EV/EBITDA	12.46	Sales past 3/5Y	19.60% 26.45%	Gross Margin	60.75%	Volatility	4.35% 5.63%	Perf 5Y	-84.05%
Dividend TTM	-	EV/Sales	1.21	EPS Y/Y TTM	120.62%	Oper. Margin	2.60%	ATR (14)	0.50	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.75	Sales Y/Y TTM	14.05%	Profit Margin	1.85%	RSI (14)	49.66	Recom	1.85
Dividend Gr. 3/5Y	- -	Current Ratio	1.75	EPS Q/Q	171.99%	SMA20	-0.31%	Beta	0.89	Target Price	13.94
Payout	0.00%	Debt/Eq	0.26	Sales Q/Q	12.94%	SMA50	0.96%	Rel Volume	0.71	Prev Close	9.35
Employees	1789	LT Debt/Eq	0.24	Earnings	May 27 AMC	SMA200	-40.22%	Avg Volume	1.96M	Price	9.38
IPO	Jul 18, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	338.60% 0.66%	Trades		Volume	1,396,408	Change	0.32%

Date	Action	Analyst	Rating Change	Price Target Change
May-28-26	Downgrade	Piper Sandler	Overweight → Neutral	$12
May-20-26	Downgrade	Wells Fargo	Overweight → Equal Weight	$9
May-15-26	Downgrade	Barclays	Overweight → Equal Weight	$10
Apr-01-26	Downgrade	Citizens	Mkt Outperform → Mkt Perform
Mar-31-26	Reiterated	Needham	Buy	$35 → $14
Mar-31-26	Downgrade	Truist	Buy → Hold	$11
Mar-31-26	Downgrade	Robert W. Baird	Outperform → Neutral	$10
Mar-31-26	Downgrade	JP Morgan	Overweight → Neutral	$16
Mar-31-26	Downgrade	Citigroup	Buy → Neutral	$10
Jan-09-26	Resumed	RBC Capital Mkts	Outperform	$26
Jan-09-26	Initiated	Wells Fargo	Overweight	$30
Dec-09-25	Initiated	Barclays	Overweight	$26
Nov-13-25	Initiated	BMO Capital Markets	Outperform	$32
Sep-05-25	Resumed	DA Davidson	Buy	$33
Aug-27-25	Initiated	Mizuho	Outperform	$36
Jan-08-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$24 → $32
Feb-26-24	Initiated	Truist	Buy	$35
Jan-17-24	Upgrade	DA Davidson	Neutral → Buy	$30 → $32
Jan-03-24	Initiated	Barclays	Overweight	$29
Apr-12-23	Initiated	Stephens	Overweight	$37

Show Previous Ratings

Jun-15-26 03:39AM	Phreesia, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PHR (PR Newswire)
Jun-11-26 01:55AM	Phreesia, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PHR (PR Newswire)
Jun-03-26 03:23PM	PHR Stockholders Have Rights - If You Lost Money Investing in Phreesia, Inc. Contact Robbins LLP for Information About Recovering Your Losses (Business Wire) -6.85%
01:56AM	Phreesia, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PHR (PR Newswire)
May-28-26 01:00AM	Phreesia Inc (PHR) Q1 2027 Earnings Call Highlights: Strong Revenue Growth and Positive Net ... (GuruFocus.com)
08:17PM	Loading…
May-27-26 08:17PM	Phreesia, Inc. Q1 2027 Earnings Call Summary (Moby)
04:25PM	Phreesia: Fiscal Q1 Earnings Snapshot (Associated Press)
04:03PM	Phreesia Announces First Quarter Fiscal 2027 Results (Business Wire)
May-20-26 09:43AM	Cigna downgraded, Humana upgraded: Wall Street's top analyst calls (The Fly)
May-15-26 09:45AM	Cisco upgraded, Doximity downgraded: Wall Street's top analyst calls (The Fly)
May-01-26 06:46AM	Phreesia Sets Release Date for Fiscal First Quarter 2027 Results (Business Wire)
Apr-14-26 04:07PM	Phreesia Named to Beckers Hospital Reviews 2026 List of Revenue Cycle Management Companies to Know (Business Wire) +5.35%
Apr-09-26 06:50AM	MediFind Becomes First Doctor Directory to Receive the Digital Medicine Society Seal (Business Wire) -7.54%
Apr-01-26 04:18AM	Phreesia's Growth Guidance Disappointed. We're Pulling Our Recommendation. (Barrons.com)
Mar-31-26 09:32AM	Western Digital upgraded, PayPal initiated: Wall Street's top analyst calls (The Fly) -26.56%
06:13AM	Loading…
06:13AM	Phreesia sinks 26% after substantial outlook cut; Wall Street downgrades shares (Investing.com)
Mar-30-26 11:00PM	Phreesia Inc (PHR) Q4 2026 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
08:15PM	Phreesia, Inc. Q4 2026 Earnings Call Summary (Moby)
04:15PM	Phreesia: Fiscal Q4 Earnings Snapshot (Associated Press)
04:03PM	Phreesia Announces Fourth Quarter Fiscal 2026 Results (Business Wire)
Mar-24-26 04:09PM	Phreesia Named One of Beckers Top Places to Work in Healthcare (Business Wire)
Mar-19-26 09:03PM	Phreesia and Sesame Workshop Win Point of Care Excellence Award for Best Unbranded Campaign (Business Wire) +5.09%
Mar-16-26 04:03PM	Phreesia Announces Refinancing of Bridge Loan with New $275 Million Revolving Credit Facility (Business Wire)
Mar-12-26 04:06PM	Phreesias Tiffany McGee Named a Top Woman Leader in Software (Business Wire)
Mar-10-26 04:06PM	Phreesia Named to the 2026 Capterra Shortlist for Appointment Scheduling (Business Wire)
Mar-05-26 04:05PM	Phreesias Tara Sheehy Named to MM+M Women to Watch (Business Wire)
Mar-03-26 06:52AM	Phreesia Network Solutions Launches ProviderConnect, a Pioneering Offering to Engage Clinicians When It Matters Most (Business Wire)
Feb-23-26 04:03PM	Phreesia Appoints Jon Kessler to Board of Directors (Business Wire) -7.95%
Feb-19-26 10:39AM	Phreesia Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses (Newsfile)
Feb-18-26 02:29PM	Phreesia Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses (Business Wire)
04:05PM	Loading…
Feb-17-26 04:05PM	Phreesia Sets Release Date for Fiscal Fourth Quarter and Fiscal Year 2026 Results (Business Wire)
Feb-11-26 04:05PM	Phreesia CEO Chaim Indig Named to The Software Reports Top 50 CEOs of 2025 (Business Wire) -5.12%
Feb-04-26 06:32PM	Can Waystar Still Stand Up to Rising Competition? (MarketBeat)
Jan-24-26 08:55AM	Phreesia price target lowered to $30 from $35 at DA Davidson (TipRanks)
Jan-15-26 08:39AM	As AI use in healthcare rises, Waystar is riding the wave (Yahoo Finance)
Jan-03-26 07:20AM	Klaviyo, Wingstop among Stephens Best Ideas for 2026 (TipRanks)
Dec-23-25 03:40AM	Phreesia Stock Has Been Crushed. We're Standing By Our Pick. (Barrons.com)
Dec-15-25 11:10PM	Phreesia (PHR) Analyst Model Updated to Reflect Company's Latest Financial Guidance for 2026-2027 (Insider Monkey)
Dec-10-25 09:35AM	Phreesia (PHR) Loses 32.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Dec-09-25 06:17PM	Why Phreesia Stock Plummeted by 23% Today (Motley Fool) -23.31%
08:44AM	Phreesia Posts Solid Earnings But Shares Drop Anyway (24/7 Wall St.)
12:00AM	Phreesia Inc (PHR) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Dec-08-25 05:30PM	Phreesia (PHR) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
04:11PM	Phreesia: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces Third Quarter Fiscal 2026 Results and Introduces Fiscal 2027 Outlook (Business Wire)
Dec-04-25 04:05PM	Phreesias Megan Turco Named to MM+M 40 Under 40 (Business Wire)
Dec-03-25 09:15AM	Stay Ahead of the Game With Phreesia (PHR) Q3 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Dec-01-25 10:00AM	Phreesia (PHR) Earnings Expected to Grow: Should You Buy? (Zacks)
Nov-20-25 05:20PM	Veeva Systems (VEEV) Surpasses Q3 Earnings and Revenue Estimates (Zacks) +5.25%
09:35AM	After Plunging 18.2% in 4 Weeks, Here's Why the Trend Might Reverse for Phreesia (PHR) (Zacks)
Nov-19-25 04:05PM	Phreesia Named to the 2025 Deloitte Technology Fast 500 (Business Wire)
Nov-13-25 05:10PM	Dare Bioscience, Inc. (DARE) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-12-25 06:00PM	KORU Medical Systems, Inc. (KRMD) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
Nov-03-25 04:04PM	Phreesia Sets Release Date for Fiscal Third Quarter 2026 Results (Business Wire)
Oct-20-25 10:49AM	Phreesia (PHR) Fell in Q3 Despite Reporting Better Results (Insider Monkey)
Sep-16-25 06:49AM	Beckers Names Phreesias Sara DiNardo as one of 2025s Rising Stars of Healthcare (Business Wire)
Sep-10-25 12:20AM	Truist Financial Raises PT on Pheresis From $35 to $36, Keeps Buy Rating (Insider Monkey)
Sep-05-25 03:05AM	Phreesia Inc (PHR) Q2 2026 Earnings Call Highlights: Record Revenue and First Positive Net Income (GuruFocus.com) -9.87%
Sep-04-25 06:00PM	Phreesia (PHR) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
05:45PM	Phreesia (PHR) Q2 Earnings and Revenues Beat Estimates (Zacks)
04:48PM	Phreesia: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Phreesia Announces Second Quarter Fiscal 2026 Results (Business Wire)
04:03PM	Phreesia to Acquire AccessOne, Expanding Its Suite of Payment Solutions (Business Wire)
Sep-02-25 04:04PM	Phreesia Launches VoiceAI, a Conversational AI Solution to Transform Call Management in Healthcare (Business Wire)
Aug-29-25 09:15AM	Exploring Analyst Estimates for Phreesia (PHR) Q2 Earnings, Beyond Revenue and EPS (Zacks)
Aug-27-25 05:15PM	Phreesia Gains A New Bull. Why the Stock Is a Buy. (Barrons.com)
Aug-14-25 05:15PM	P3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Aug-12-25 04:05PM	Phreesia Named to the 2025 Capterra Shortlist for Patient Engagement and Medical Scheduling (Business Wire)
Aug-08-25 07:10AM	Tempus AI (TEM) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
Aug-07-25 04:05PM	Phreesia Sets Release Date for Fiscal Second Quarter 2026 Results (Business Wire)
Aug-06-25 06:10PM	Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
01:00AM	Phreesia Is Turning Profitable. Buy This Small-Cap Healthcare Tech Leader. (Barrons.com)
Jul-30-25 04:05PM	New Research Illustrates Gaps in COPD Care and the Need for Better Patient-Provider Communication (Business Wire)
Jul-25-25 07:45AM	3 Red-Hot Growth Stocks to Buy in 2025 (Motley Fool)
Jul-15-25 12:00PM	All You Need to Know About Phreesia (PHR) Rating Upgrade to Buy (Zacks)
Jul-09-25 04:05PM	Phreesia Named in Black Book Researchs List of 2025s Top-Rated Vendors for Patient Access and Front-End Management Solutions in Revenue Cycle Management (Business Wire)
Jul-08-25 08:49AM	Indig: AI has been wildly effective for us, our providers, and patients (CNBC TV)
Jun-12-25 04:05PM	Beckers Names Phreesias Kristin Roberts as one of 2025s 100 Women in Health IT to Know (Business Wire) -5.57%
Jun-02-25 12:00PM	Phreesia (PHR) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
May-29-25 11:33PM	Q1 Earnings Outperformers: Phreesia (NYSE:PHR) And The Rest Of The Healthcare Technology for Providers Stocks (StockStory)
08:55AM	Morning Movers: Abercrombie & Fitch skyrockets following first quarter results (TipRanks)
03:03AM	Phreesia Inc (PHR) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic AI ... (GuruFocus.com)
May-28-25 12:25PM	PHR Q1 Earnings Call: Revenue Misses, Profitability Surges Amid Product Expansion (StockStory) -6.61%
12:25PM	PHR Q1 Earnings Call: Profitability Surges Amid Product Expansion (StockStory)
09:30AM	Here's What Key Metrics Tell Us About Phreesia (PHR) Q1 Earnings (Zacks)
08:15AM	Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:17AM	Phreesia (NYSE:PHR) Surprises With Q1 Sales (StockStory)
07:09AM	Phreesia: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
07:03AM	Phreesia Announces First Quarter Fiscal 2026 Results (Business Wire)
May-27-25 03:03AM	Phreesia (PHR) Reports Q1: Everything You Need To Know Ahead Of Earnings (StockStory)
May-26-25 09:15AM	Gear Up for Phreesia (PHR) Q1 Earnings: Wall Street Estimates for Key Metrics (Zacks)
May-21-25 12:01AM	3 Reasons to Sell PHR and 1 Stock to Buy Instead (StockStory)
May-08-25 07:20AM	Privia Health (PRVA) Misses Q1 Earnings Estimates (Zacks)
May-07-25 07:05PM	TruBridge (TBRG) Lags Q1 Earnings Estimates (Zacks)
May-06-25 04:05PM	Phreesia Updates May 28, 2025, Earnings Release Information for Fiscal First Quarter 2026 Results (Business Wire)
Apr-29-25 09:01AM	1 Cash-Heavy Stock with Impressive Fundamentals and 2 to Ignore (StockStory)
06:40AM	Phreesia Sets Release Date for Fiscal First Quarter 2026 Results (Business Wire)
05:06AM	Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks (StockStory)
Apr-28-25 05:04AM	Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks (StockStory)
Apr-11-25 01:15PM	Buy Certara After The FDA Announcement (Seeking Alpha)

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Co-FounderMr. Chaim Indig

Co-Founder & President of Provider SolutionsMr. Evan Roberts

Chief Financial OfficerMr. Balaji Gandhi

General Counsel & SecretaryMs. Allison C. Hoffman J.D.

President of Network SolutionsMr. David Linetsky

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hui Yvonne	Principal Accounting Officer	May 18 '26	Sale	8.85	431	3,814	24,233	May 20 04:06 PM
Hui Yvonne	Officer	May 18 '26	Proposed Sale	8.85	431	3,814		May 18 11:35 AM
Hui Yvonne	Principal Accounting Officer	Apr 17 '26	Sale	9.28	1,327	12,315	24,664	Apr 21 04:36 PM
Hoffman Allison C	General Counsel & Secretary	Apr 20 '26	Sale	9.06	6,176	55,955	157,309	Apr 21 04:35 PM
Hoffman Allison C	Officer	Apr 20 '26	Proposed Sale	9.06	6,176	55,955		Apr 20 09:55 AM
Hui Yvonne	Principal Accounting Officer	Apr 16 '26	Sale	9.08	10,063	91,372	25,991	Apr 17 04:58 PM
Hui Yvonne	Officer	Apr 17 '26	Proposed Sale	9.28	1,327	12,315		Apr 17 09:34 AM
Hui Yvonne	Officer	Apr 16 '26	Proposed Sale	9.08	10,063	91,372		Apr 16 10:05 AM
Hoffman Allison C	General Counsel & Secretary	Apr 10 '26	Sale	8.07	14,483	116,878	163,485	Apr 13 08:09 PM
Linetsky David	President, Network Solutions	Apr 10 '26	Sale	8.07	8,332	67,239	224,056	Apr 13 08:01 PM
Hoffman Allison C	Officer	Apr 10 '26	Proposed Sale	8.07	14,483	116,878		Apr 10 10:48 AM
Linetsky David	Officer	Apr 10 '26	Proposed Sale	8.07	8,332	67,239		Apr 10 10:32 AM
Pale Fire Capital SE	10% Owner	Mar 31 '26	Buy	8.16	1,000,500	8,160,478	8,649,329	Apr 02 06:45 PM
Pale Fire Capital SE	10% Owner	Apr 01 '26	Buy	8.43	168,764	1,421,938	8,818,093	Apr 02 06:45 PM
Pale Fire Capital SE	10% Owner	Apr 02 '26	Buy	8.31	106,236	882,407	8,924,329	Apr 02 06:45 PM
Gandhi Balaji	Chief Financial Officer	Mar 25 '26	Sale	11.26	3,829	43,128	146,740	Mar 27 05:21 PM
Hoffman Allison C	General Counsel & Secretary	Mar 23 '26	Sale	11.97	6,176	73,927	163,485	Mar 25 05:00 PM
Gandhi Balaji	Officer	Mar 25 '26	Proposed Sale	11.26	3,829	43,128		Mar 25 03:59 PM
Hoffman Allison C	Officer	Mar 23 '26	Proposed Sale	11.97	6,176	73,927		Mar 23 09:57 AM
Pale Fire Capital SE	10% Owner	Mar 19 '26	Buy	11.69	780,009	9,118,227	7,648,829	Mar 19 06:52 PM
Pale Fire Capital SE	10% Owner	Mar 18 '26	Buy	11.15	519,196	5,790,645	6,868,820	Mar 19 06:52 PM
Pale Fire Capital SE	10% Owner	Mar 17 '26	Buy	11.20	303,300	3,395,807	6,349,624	Mar 19 06:52 PM
Linetsky David	President, Network Solutions	Mar 18 '26	Sale	11.06	107	1,183	11,068	Mar 19 04:17 PM
Linetsky David	Member of immediate family of	Mar 18 '26	Proposed Sale	11.06	107	1,183		Mar 18 03:29 PM
VanDuyn Amy Beth	SVP, Human Resources	Jan 16 '26	Sale	16.36	2,202	36,018	157,349	Jan 20 05:11 PM
VanDuyn Amy Beth	SVP, Human Resources	Jan 15 '26	Sale	16.38	687	11,253	159,551	Jan 20 05:11 PM
Roberts Evan	President, Provider Solutions	Jan 16 '26	Sale	16.36	6,268	102,524	826,554	Jan 20 05:11 PM
Roberts Evan	President, Provider Solutions	Jan 15 '26	Sale	16.38	1,810	29,647	832,822	Jan 20 05:11 PM
Linetsky David	President, Network Solutions	Jan 16 '26	Sale	16.36	6,038	98,762	223,942	Jan 20 05:10 PM
Linetsky David	President, Network Solutions	Jan 15 '26	Sale	16.38	1,743	28,549	229,980	Jan 20 05:10 PM
Indig Chaim	Chief Executive Officer	Jan 16 '26	Sale	16.36	9,595	156,943	1,361,535	Jan 20 05:08 PM
Indig Chaim	Chief Executive Officer	Jan 15 '26	Sale	16.38	3,038	49,761	1,371,130	Jan 20 05:08 PM
Hoffman Allison C	General Counsel & Secretary	Jan 16 '26	Sale	16.36	3,995	65,345	169,661	Jan 20 05:08 PM
Hoffman Allison C	General Counsel & Secretary	Jan 15 '26	Sale	16.38	1,106	18,116	173,656	Jan 20 05:08 PM
Gandhi Balaji	Chief Financial Officer	Jan 16 '26	Sale	16.36	4,687	76,664	150,569	Jan 20 05:07 PM
Gandhi Balaji	Chief Financial Officer	Jan 15 '26	Sale	16.38	975	15,970	155,256	Jan 20 05:07 PM
Hui Yvonne	Principal Accounting Officer	Jan 15 '26	Sale	16.17	379	6,128	29,166	Jan 16 05:09 PM
Hui Yvonne	Principal Accounting Officer	Jan 14 '26	Sale	16.36	365	5,971	29,545	Jan 16 05:09 PM
Linetsky David	Officer	Jan 16 '26	Proposed Sale	16.36	6,038	98,762		Jan 16 04:27 PM
VanDuyn Amy Beth	Officer	Jan 16 '26	Proposed Sale	16.36	2,202	36,018		Jan 16 04:17 PM
Hoffman Allison C	Officer	Jan 16 '26	Proposed Sale	16.36	3,995	65,345		Jan 16 04:03 PM
Indig Chaim	Officer	Jan 16 '26	Proposed Sale	16.36	9,595	156,944		Jan 16 03:50 PM
Gandhi Balaji	Officer	Jan 16 '26	Proposed Sale	16.36	4,687	76,664		Jan 16 03:48 PM
Roberts Evan	Officer	Jan 16 '26	Proposed Sale	16.36	6,268	102,524		Jan 16 03:44 PM
VanDuyn Amy Beth	Officer	Jan 15 '26	Proposed Sale	16.38	687	11,253		Jan 15 03:34 PM
Hoffman Allison C	Officer	Jan 15 '26	Proposed Sale	16.38	1,106	18,116		Jan 15 03:27 PM
Linetsky David	Officer	Jan 15 '26	Proposed Sale	16.38	1,743	28,549		Jan 15 03:24 PM
Gandhi Balaji	Officer	Jan 15 '26	Proposed Sale	16.38	975	15,970		Jan 15 03:23 PM
Roberts Evan	Officer	Jan 15 '26	Proposed Sale	16.38	1,810	29,647		Jan 15 03:18 PM
Indig Chaim	Officer	Jan 15 '26	Proposed Sale	16.38	3,038	49,761		Jan 15 03:13 PM
Hui Yvonne	Officer	Jan 15 '26	Proposed Sale	16.17	379	6,128		Jan 15 10:31 AM
Hui Yvonne	Officer	Jan 14 '26	Proposed Sale	16.36	365	5,971		Jan 14 03:12 PM
VanDuyn Amy Beth	SVP, Human Resources	Jan 08 '26	Sale	17.01	2,602	44,252	160,238	Jan 12 05:06 PM
Roberts Evan	President, Provider Solutions	Jan 08 '26	Sale	17.01	6,317	107,434	834,632	Jan 12 05:05 PM
Linetsky David	President, Network Solutions	Jan 08 '26	Sale	17.01	6,106	103,845	231,723	Jan 12 05:01 PM
Indig Chaim	Chief Executive Officer	Jan 08 '26	Sale	17.01	8,440	143,540	1,374,168	Jan 12 05:00 PM
Hui Yvonne	Principal Accounting Officer	Jan 08 '26	Sale	17.47	372	6,499	29,910	Jan 12 04:58 PM
Hoffman Allison C	General Counsel & Secretary	Jan 08 '26	Sale	17.01	6,585	111,992	174,762	Jan 12 04:55 PM
Gandhi Balaji	Chief Financial Officer	Jan 08 '26	Sale	17.01	8,009	136,210	156,231	Jan 12 04:51 PM
Gandhi Balaji	Officer	Jan 08 '26	Proposed Sale	17.01	8,009	136,210		Jan 08 04:50 PM
Indig Chaim	Officer	Jan 08 '26	Proposed Sale	17.01	8,440	143,540		Jan 08 04:43 PM
Roberts Evan	Officer	Jan 08 '26	Proposed Sale	17.01	6,317	107,434		Jan 08 04:32 PM
VanDuyn Amy Beth	Officer	Jan 08 '26	Proposed Sale	17.01	2,602	44,252		Jan 08 04:28 PM
Hoffman Allison C	Officer	Jan 08 '26	Proposed Sale	17.01	6,585	111,992		Jan 08 04:27 PM
Linetsky David	Officer	Jan 08 '26	Proposed Sale	17.01	6,106	103,845		Jan 08 04:21 PM
Hui Yvonne	Officer	Jan 08 '26	Proposed Sale	17.47	372	6,499		Jan 08 09:43 AM
VanDuyn Amy Beth	SVP, Human Resources	Dec 19 '25	Option Exercise	4.71	18,000	84,780	162,840	Dec 22 05:42 PM
Linetsky David	President, Network Solutions	Dec 17 '25	Sale	16.49	94	1,550	9,789	Dec 19 05:27 PM
Roberts Evan	President, Provider Solutions	Dec 17 '25	Option Exercise	5.05	50,000	252,316	840,949	Dec 19 05:26 PM
Hui Yvonne	Principal Accounting Officer	Dec 17 '25	Sale	16.25	426	6,922	29,910	Dec 19 05:25 PM
Linetsky David	Member of immediate family of	Dec 17 '25	Proposed Sale	16.49	94	1,550		Dec 17 03:07 PM
Hui Yvonne	Officer	Dec 17 '25	Proposed Sale	16.25	426	6,922		Dec 17 09:45 AM
Gandhi Balaji	Chief Financial Officer	Oct 17 '25	Sale	22.36	885	19,790	98,240	Oct 21 05:02 PM
Hoffman Allison C	General Counsel & Secretary	Oct 17 '25	Sale	22.36	1,241	27,750	135,737	Oct 21 05:00 PM
Indig Chaim	Chief Executive Officer	Oct 17 '25	Sale	22.36	3,163	70,728	1,252,608	Oct 21 04:53 PM
Linetsky David	President, Network Solutions	Oct 17 '25	Sale	22.36	2,059	46,042	171,829	Oct 21 04:50 PM
Roberts Evan	President, Provider Solutions	Oct 17 '25	Sale	22.36	1,888	42,218	724,949	Oct 21 04:48 PM
VanDuyn Amy Beth	SVP, Human Resources	Oct 17 '25	Sale	22.36	639	14,289	111,840	Oct 21 04:46 PM
Gandhi Balaji	Officer	Oct 17 '25	Proposed Sale	22.36	885	19,790		Oct 17 04:31 PM
Indig Chaim	Officer	Oct 17 '25	Proposed Sale	22.36	3,163	70,728		Oct 17 04:26 PM
Hoffman Allison C	Officer	Oct 17 '25	Proposed Sale	22.36	1,241	27,750		Oct 17 04:24 PM
Linetsky David	Officer	Oct 17 '25	Proposed Sale	22.36	2,059	46,042		Oct 17 04:21 PM
Hui Yvonne	Principal Accounting Officer	Oct 15 '25	Sale	23.05	302	6,960	30,336	Oct 17 04:18 PM
VanDuyn Amy Beth	Officer	Oct 17 '25	Proposed Sale	22.36	639	14,289		Oct 17 04:18 PM
Roberts Evan	Officer	Oct 17 '25	Proposed Sale	22.36	1,888	42,218		Oct 17 04:15 PM
Hui Yvonne	Officer	Oct 15 '25	Proposed Sale	23.05	302	6,960		Oct 15 03:17 PM
Linetsky David	President, Network Solutions	Sep 18 '25	Sale	23.94	93	2,226	9,883	Sep 22 04:15 PM
Gandhi Balaji	Chief Financial Officer	Sep 16 '25	Sale	23.28	4,183	97,399	99,125	Sep 18 05:44 PM
Hoffman Allison C	General Counsel & Secretary	Sep 16 '25	Sale	23.28	3,133	72,950	139,037	Sep 18 05:43 PM
Hoffman Allison C	General Counsel & Secretary	Sep 17 '25	Sale	23.50	2,059	48,386	136,978	Sep 18 05:43 PM
Hui Yvonne	Principal Accounting Officer	Sep 16 '25	Sale	23.28	940	21,887	30,638	Sep 18 05:42 PM
Indig Chaim	Chief Executive Officer	Sep 16 '25	Sale	23.28	6,328	147,344	1,255,771	Sep 18 05:40 PM
Linetsky David	President, Network Solutions	Sep 16 '25	Sale	23.28	2,165	50,411	174,952	Sep 18 05:38 PM
Linetsky David	President, Network Solutions	Sep 17 '25	Sale	23.50	1,064	25,004	173,888	Sep 18 05:38 PM
Roberts Evan	President, Provider Solutions	Sep 16 '25	Sale	23.28	3,761	87,573	726,837	Sep 18 05:33 PM
VanDuyn Amy Beth	SVP, Human Resources	Sep 16 '25	Sale	23.28	1,762	41,027	112,479	Sep 18 05:30 PM
Linetsky David	Member of immediate family of	Sep 18 '25	Proposed Sale	23.94	93	2,226		Sep 18 04:12 PM
Linetsky David	Officer	Sep 17 '25	Proposed Sale	23.50	1,064	25,004		Sep 17 10:59 AM
Hoffman Allison C	Officer	Sep 17 '25	Proposed Sale	23.50	2,059	48,386		Sep 17 10:46 AM
Hui Yvonne	Officer	Sep 16 '25	Proposed Sale	23.28	940	21,887		Sep 16 04:21 PM

Open in Screener

TDOC

Teladoc Health Inc

Jun 18 • 04:00PM ET

8.07

+0.48 6.32 %

Healthcare • Health Information Services • USA • Small • NYSE

TDOC Teladoc Health Inc daily Stock Chart

Peers: DOCS AMWL GDRX LFMD OMCL EVH PHR DH HIMS HQY

| Held by: VTI IWM VB AVUV VXF VBR IWN VBK FNDA DFSV

Index	RUT	P/E	-	EPS (ttm)	-0.96	Insider Own	2.57%	Shs Outstand	180.43M	Perf Week	10.40%
Market Cap	1.46B	Forward P/E	-	EPS next Y	-0.64	Insider Trans	-4.28%	Shs Float	175.87M	Perf Month	22.09%
Enterprise Value	1.74B	PEG	-	EPS next Q	-0.25	Inst Own	77.86%	Short Float	15.76%	Perf Quarter	46.20%
Income	-171.15M	P/S	0.58	EPS this Y	20.08%	Inst Trans	5.18%	Short Ratio	5.94	Perf Half Y	8.91%
Sales	2.51B	P/B	1.09	EPS next Y	30.16%	ROA	-5.48%	Short Interest	27.71M	Perf YTD	15.29%
Book/sh	7.41	P/C	1.94	EPS next 5Y	26.53%	ROE	-12.39%	52W High	9.77 -17.40%	Perf Year	15.12%
Cash/sh	4.16	P/FCF	5.28	EPS past 3/5Y	76.23% 26.67%	ROIC	-7.24%	52W Low	4.40 83.41%	Perf 3Y	-67.59%
Dividend Est.	-	EV/EBITDA	7.81	Sales past 3/5Y	1.68% 18.26%	Gross Margin	54.63%	Volatility	5.49% 5.64%	Perf 5Y	-94.84%
Dividend TTM	-	EV/Sales	0.69	EPS Y/Y TTM	83.75%	Oper. Margin	-6.25%	ATR (14)	0.40	Perf 10Y	-37.25%
Dividend Ex-Date	-	Quick Ratio	2.63	Sales Y/Y TTM	-1.50%	Profit Margin	-6.81%	RSI (14)	69.65	Recom	2.52
Dividend Gr. 3/5Y	- -	Current Ratio	2.70	EPS Q/Q	33.27%	SMA20	11.53%	Beta	2.11	Target Price	7.20
Payout	-	Debt/Eq	0.78	Sales Q/Q	-2.47%	SMA50	22.44%	Rel Volume	1.24	Prev Close	7.59
Employees	5600	LT Debt/Eq	0.77	Earnings	Apr 29 AMC	SMA200	18.87%	Avg Volume	4.66M	Price	8.07
IPO	Jul 01, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.51% 0.49%	Trades		Volume	5,795,434	Change	6.32%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-10-26	Upgrade	Deutsche Bank	Hold → Buy	$11
Feb-26-26	Upgrade	BofA Securities	Neutral → Buy	$7
Dec-09-25	Initiated	Barclays	Equal Weight	$8.50
Nov-13-25	Initiated	BMO Capital Markets	Market Perform	$8
Jul-25-25	Initiated	Mizuho	Neutral	$10
Nov-15-24	Initiated	Goldman	Buy	$14
Sep-17-24	Reiterated	Jefferies	Hold	$8 → $10
Feb-29-24	Initiated	Cantor Fitzgerald	Overweight	$22
Feb-26-24	Initiated	Leerink Partners	Market Perform	$17
Jan-17-24	Downgrade	DA Davidson	Buy → Neutral	$33 → $22
Jan-03-24	Initiated	Barclays	Overweight	$26
Apr-12-23	Initiated	Stephens	Equal-Weight	$25
Feb-23-23	Upgrade	SVB Securities	Market Perform → Outperform	$34
Oct-24-22	Upgrade	Guggenheim	Sell → Neutral
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-07-22	Initiated	Truist	Hold	$35
Aug-17-22	Downgrade	Guggenheim	Neutral → Sell	$25
Aug-12-22	Initiated	DA Davidson	Buy	$45
Aug-02-22	Downgrade	Cowen	Outperform → Market Perform	$58 → $34
Aug-02-22	Downgrade	Berenberg	Buy → Hold	$35

Show Previous Ratings

Jun-05-26 03:52PM	Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
May-28-26 12:56PM	TDOC Stock Surpasses 200-DMA With Conviction After Walmart Partnership BofA Sees Its Expanded Distribution As 'Modest Positive' (Stocktwits) +13.96%
09:00AM	Teladoc Health Expands Access to Care Through Walmart's Better Care Services (GlobeNewswire)
Apr-30-26 08:30AM	Teladoc Health, Inc. Q1 2026 Earnings Call Summary (Moby)
05:34AM	Qualcomm jumps on AI hopes, and other early market movers (MarketWatch)
03:19AM	Loading…
03:19AM	Teladoc Health Inc (TDOC) Q1 2026 Earnings Call Highlights: Strong Revenue Performance Amid ... (GuruFocus.com)
Apr-29-26 04:05PM	Teladoc Health Reports First Quarter 2026 Results (GlobeNewswire)
Apr-15-26 04:05PM	Teladoc Health to Announce First Quarter 2026 Financial Results (GlobeNewswire) +5.73% +5.05%
Apr-13-26 12:20PM	Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
Apr-10-26 09:26AM	Why Is HIMS Stock Down 40%? (Trefis)
Apr-01-26 09:46AM	Disney upgraded, Nike downgraded: Wall Street's top analyst calls (The Fly)
Mar-30-26 04:30PM	Teladoc Health Appoints Susan Salka, Experienced Healthcare Executive, to Its Board of Directors (GlobeNewswire) +6.03%
Mar-11-26 06:00AM	Teladoc (TDOC) Surges 5.1%: Is This an Indication of Further Gains? (Zacks)
Mar-10-26 03:36PM	Why Teladoc (TDOC) Stock Is Up Today (StockStory) +5.09%
10:49AM	Teladoc Health Stock Pops - Here's Why (Benzinga)
10:09AM	Loading…
10:09AM	Wall Street Turns Bullish on HIMS, TDOC and ALEC as Partnerships Reshape Risk Profiles (24/7 Wall St.)
Mar-05-26 09:35AM	Hims and Hers Expands Its Technology Driven Consumer Health Platform (Zacks)
Mar-04-26 04:05PM	Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 (GlobeNewswire)
Mar-03-26 04:05PM	Teladoc Health to Participate in Upcoming Investor Conference (GlobeNewswire)
Feb-28-26 10:06PM	Teladoc Health Q4 Earnings Call Highlights (MarketBeat)
Feb-26-26 12:39PM	Teladoc Tops Q4 Earnings Estimates on International Growth & Lower Costs (Zacks) +15.05%
12:18PM	What's Driving Teladoc Health's Rally? (Benzinga)
12:11PM	Why Teladoc (TDOC) Stock Is Up Today (StockStory)
09:30AM	Here's What Key Metrics Tell Us About Teladoc (TDOC) Q4 Earnings (Zacks)
07:03AM	Teladoc projects lower integrated care membership amid ACA subsidy lapse (Healthcare Dive)
12:02AM	Teladoc Health Inc (TDOC) Q4 2025 Earnings Call Highlights: Navigating Challenges and Opportunities (GuruFocus.com)
Feb-25-26 05:03PM	Teladoc (NYSE:TDOC) Surprises With Q4 CY2025 Sales (StockStory)
04:05PM	Teladoc Health Reports Fourth Quarter and Full Year 2025 Results (GlobeNewswire)
Feb-23-26 10:05PM	Teladoc (TDOC) Q4 Earnings: What To Expect (StockStory)
10:33AM	Nvidia, Joby, CoreWeave, Lucid and More Stocks with Earnings This Week (Benzinga)
09:58AM	Loading…
09:58AM	BofA and Goldman Cut Teladoc (TDOC) Price Targets (Insider Monkey)
09:15AM	Stay Ahead of the Game With Teladoc (TDOC) Q4 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Feb-19-26 11:43PM	3 Unprofitable Stocks with Questionable Fundamentals (StockStory)
11:27AM	Teladoc Q4 Earnings: Can Integrated Care Strength Save Profits? (Zacks)
09:40AM	Is Teladoc Health (TDOC) Stock Undervalued Right Now? (Zacks)
Feb-18-26 07:44PM	BofA Lowers Teladoc (TDOC) PT on Peer Multiple Compression, Soft Sensor Tower Trends (Insider Monkey)
04:30PM	Teladoc Health Appoints Michael Smith, Experienced Insurance and Financial Services Executive, to Its Board of Directors (GlobeNewswire)
Feb-17-26 06:15PM	Teladoc (TDOC) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
Feb-12-26 09:59AM	Hims & Hers Strengthens Integrated Personalized Digital Care Platform (Zacks)
Feb-11-26 11:56AM	Telehealth stocks pressured as Amazon Pharmacy expands prescription delivery (Investing.com)
11:13AM	HIMS Dips 55.8% in 3 Months: Should You Still Hold the Stock or Sell? (Zacks)
Feb-10-26 06:15PM	Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
Feb-05-26 04:30PM	Teladoc Health to Announce Fourth Quarter 2025 Financial Results (GlobeNewswire) +5.92%
Feb-04-26 02:36PM	Jim Cramer on Teladoc: "I Don't See Any Reason to Own It" (Insider Monkey)
Feb-02-26 06:15PM	Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know (Zacks)
Jan-29-26 04:50AM	Chuck Divita on why 2026 is Teladocs execution year (Healthcare Dive)
Jan-28-26 04:30PM	Once Medicare Stops Covering Telehealth Services, Will Teladoc Health Stock be in Trouble? (Motley Fool)
07:10AM	Danaher (DHR) Beats Q4 Earnings and Revenue Estimates (Zacks)
Jan-27-26 06:15PM	Teladoc (TDOC) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks) -6.04%
03:10PM	Why Teladoc (TDOC) Shares Are Plunging Today (StockStory)
10:20AM	Are Telehealth Stocks Set to Tumble in 2026? (Motley Fool)
08:55AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Jan-21-26 10:50PM	2 Beaten-Down Stocks That Could Sink Even More in 2026 (Motley Fool)
08:55AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
Jan-20-26 11:04PM	3 Reasons to Avoid TDOC and 1 Stock to Buy Instead (StockStory)
01:00PM	Teladoc and EverQuote Shares Plummet, What You Need To Know (StockStory)
Jan-19-26 12:13PM	Hims & Hers Expands Platform-Led Access to Digital Healthcare (Zacks)
Jan-13-26 06:15PM	Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks) -5.44%
Jan-12-26 06:00AM	Teladoc Health Launches Enhanced 24/7 Care Service (GlobeNewswire)
Jan-08-26 11:34PM	3 Value Stocks with Open Questions (StockStory)
09:54AM	Hims & Hers Plunges 39.2% in 3 Months: Time to Hold the Stock or Sell? (Zacks)
Jan-07-26 06:15PM	Why Teladoc (TDOC) Dipped More Than Broader Market Today (Zacks) -5.37%
Jan-05-26 04:30PM	Teladoc Health to Participate in Upcoming Investor Conference (GlobeNewswire) +9.89%
Jan-04-26 11:23AM	3 Reasons to Forget Teladoc Health Stock (Motley Fool)
Dec-30-25 12:41PM	HIMS Scales AI-Enabled Care as Platform Depth and Engagement Expand (Zacks)
Dec-29-25 11:35PM	3 Volatile Stocks That Concern Us (StockStory)
Dec-27-25 01:01PM	Down 98% From Its All-Time High? Is It Finally Time to Buy This Former Market Darling? (Motley Fool)
Dec-24-25 12:22PM	HIMS vs. TDOC: Which Telehealth Stock Looks More Compelling? (Zacks)
Dec-22-25 11:55AM	Why Teladoc (TDOC) Stock Is Up Today (StockStory)
09:53AM	Barclays Initiates Coverage on Teladoc (TDOC) with Equal Weight at $8.50 (Insider Monkey)
Dec-13-25 11:35AM	Private Markets: Musks SpaceX targets 2026 IPO at valuation of $1.5T (TipRanks)
07:13AM	Forget Teladoc and Buy This Healthcare Stock Instead (Motley Fool)
Dec-11-25 10:32AM	Hims & Hers Expands Its Technology-Driven Personalized Virtual Care (Zacks)
Dec-09-25 11:25AM	Hims & Hers Plunges 29.1% in 6 Months: Time to Hold the Stock or Sell? (Zacks)
Dec-01-25 05:57AM	3 Unprofitable Stocks We Approach with Caution (StockStory)
Nov-28-25 11:30AM	Why Is Teladoc (TDOC) Down 14.8% Since Last Earnings Report? (Zacks)
Nov-26-25 04:05PM	Teladoc Health to Participate in Upcoming Investor Conference (GlobeNewswire)
Nov-24-25 04:55PM	Teladoc, Angi, Upwork, and ACV Auctions Shares Are Soaring, What You Need To Know (StockStory)
Nov-21-25 11:06AM	Does Teladoc's Acquisition Strategy Boost Growth and Global Footprint? (Zacks)
Nov-20-25 04:55PM	Teladoc and Netflix Shares Are Falling, What You Need To Know (StockStory)
11:42AM	TDOC vs. LFMD: Which Telehealth Stock Is Better for Your Portfolio? (Zacks)
Nov-19-25 10:32PM	Online Marketplace Stocks Q3 Highlights: Teladoc (NYSE:TDOC) (StockStory)
12:24PM	TDOC Partners With TytoCare to Expand At-Home Exam Capabilities (Zacks)
Nov-18-25 11:43AM	Hims & Hers Plunges 15.6% in 3 Months: Time to Hold the Stock or Sell? (Zacks)
09:00AM	TytoCare Integrates With Teladoc Health to Augment Virtual Primary and Urgent Care (PR Newswire)
Nov-17-25 11:23AM	Is Teladoc Health Accelerating Growth Through Global Expansion? (Zacks)
Nov-15-25 11:42PM	Teladoc Health Held In-Line Rating in Late Ocotber as Evercore Reversed Price Target Back to $8 (Insider Monkey)
Nov-13-25 03:55PM	Teladoc, MercadoLibre, Reddit, Lyft, and Wayfair Stocks Trade Down, What You Need To Know (StockStory) -5.35%
Nov-11-25 01:26PM	Teladoc Health's Q3 Loss Widens Y/Y on Weak BetterHelp Unit (Zacks)
12:43PM	Hims & Hers Scales Technology-Enabled, Vertically Integrated Care (Zacks)
Nov-10-25 12:47PM	How is Teladoc Health Placed in the Growing Telemedicine Market? (Zacks)
Nov-06-25 04:30PM	Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 (GlobeNewswire) -5.46%
01:31PM	1 Russell 2000 Stock to Keep an Eye On and 2 Facing Challenges (StockStory)
Nov-05-25 12:23PM	How to Play Teladoc Health Stock Post Q3 Results: Buy, Hold or Sell? (Zacks)
06:45AM	Why Teladoc Stock Zoomed Almost 12% Higher in October (Motley Fool)
12:32AM	The 5 Most Interesting Analyst Questions From Teladoc's Q3 Earnings Call (StockStory)
Nov-04-25 11:42AM	Sovato raises Series B funds to advance remote robotic surgery platform (Medical Device Network)
Nov-03-25 09:24PM	Is This Beaten-Down Stock Finally on the Road to Recovery? (Motley Fool) -5.68%
04:01PM	Why Teladoc (TDOC) Shares Are Getting Obliterated Today (StockStory)
Oct-31-25 07:38AM	Harry Yous Berto Embraces Clinic-in-a-Box with OnMed Event Flash (Exec Edge)

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

CPAMr. Charles Divita III

Chief Legal Officer & SecretaryMr. Adam Christian Vandervoort J.D.

President of InternationalMr. Carlos Nueno

President of U.S. Group HealthMs. Kelly M. Bliss

M.D.Dr. George Byron Brooks BS EE

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DIVITA CHARLES III	CHIEF EXECUTIVE OFFICER	Jun 11 '26	Sale	6.94	18,074	125,470	414,622	Jun 12 04:05 PM
DIVITA CHARLES III	Officer	Jun 11 '26	Proposed Sale	6.94	18,074	125,461		Jun 11 03:22 PM
Rodrigues Fernando M.	President of BetterHelp	Jun 03 '26	Sale	7.40	9,572	70,833	0	Jun 04 04:05 PM
Rodrigues Fernando M.	President of BetterHelp	Jun 02 '26	Sale	7.63	5,677	43,298	9,572	Jun 03 04:26 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Jun 02 '26	Sale	7.63	7,906	60,299	110,261	Jun 03 04:25 PM
Nueno Carlos	President, International	Jun 02 '26	Sale	7.63	6,196	47,257	57,671	Jun 03 04:25 PM
DIVITA CHARLES III	CHIEF EXECUTIVE OFFICER	Jun 02 '26	Sale	7.63	19,132	145,920	389,894	Jun 03 04:25 PM
Catapano Joseph Ronald	Chief Accounting Officer	Jun 02 '26	Sale	7.63	284	2,166	10,837	Jun 03 04:25 PM
Bliss Kelly	President, U.S. Group Health	Jun 02 '26	Sale	7.63	7,679	58,568	92,378	Jun 03 04:24 PM
Rodrigues Fernando M.	Officer	Jun 03 '26	Proposed Sale	7.40	9,572	70,833		Jun 03 10:42 AM
DIVITA CHARLES III	Officer	Jun 02 '26	Proposed Sale	7.63	19,132	145,920		Jun 02 04:58 PM
Rodrigues Fernando M.	Officer	Jun 02 '26	Proposed Sale	7.63	5,677	43,298		Jun 02 04:58 PM
Vandervoort Adam C	Officer	Jun 02 '26	Proposed Sale	7.63	7,906	60,299		Jun 02 04:49 PM
Bliss Kelly	Officer	Jun 02 '26	Proposed Sale	7.63	7,679	58,568		Jun 02 04:48 PM
Nueno Carlos	Officer	Jun 02 '26	Proposed Sale	7.63	6,196	47,257		Jun 02 04:46 PM
Catapano Joseph Ronald	Chief Accounting Officer	Apr 02 '26	Sale	5.11	675	3,452	10,249	Apr 03 03:58 PM
DIVITA CHARLES III	CHIEF EXECUTIVE OFFICER	Mar 11 '26	Sale	5.49	27,731	152,243	364,784	Mar 12 04:06 PM
DIVITA CHARLES III	Officer	Mar 11 '26	Proposed Sale	5.49	27,731	152,252		Mar 11 03:35 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Mar 02 '26	Sale	5.12	27,083	138,584	103,239	Mar 03 04:11 PM
DIVITA CHARLES III	CHIEF EXECUTIVE OFFICER	Mar 02 '26	Sale	5.12	50,145	256,592	327,862	Mar 03 04:09 PM
Bliss Kelly	President, U.S. Group Health	Mar 02 '26	Sale	5.12	26,647	136,353	84,747	Mar 03 04:08 PM
Rodrigues Fernando M.	Officer	Mar 03 '26	Proposed Sale	4.98	25,086	124,973		Mar 03 11:18 AM
Rodrigues Fernando M.	Officer	Mar 02 '26	Proposed Sale	5.12	16,314	83,474		Mar 02 05:12 PM
DIVITA CHARLES III	Officer	Mar 02 '26	Proposed Sale	5.12	50,145	256,577		Mar 02 05:10 PM
Bliss Kelly	Officer	Mar 02 '26	Proposed Sale	5.12	26,647	136,345		Mar 02 04:59 PM
Vandervoort Adam C	Officer	Mar 02 '26	Proposed Sale	5.12	27,083	138,576		Mar 02 04:57 PM
Nueno Carlos	Officer	Mar 02 '26	Proposed Sale	5.12	20,165	103,178		Mar 02 04:49 PM
Catapano Joseph Ronald	Chief Accounting Officer	Jan 05 '26	Sale	7.14	758	5,416	6,686	Jan 06 04:05 PM
DIVITA CHARLES III	CHIEF EXECUTIVE OFFICER	Dec 11 '25	Sale	7.63	17,138	130,837	201,036	Dec 11 04:23 PM
DIVITA CHARLES III	Officer	Dec 11 '25	Proposed Sale	7.63	17,138	130,837		Dec 11 03:46 PM
Rodrigues Fernando M.	President of BetterHelp	Dec 03 '25	Sale	7.48	4,209	31,483	0	Dec 03 09:04 PM
Rodrigues Fernando M.	President of BetterHelp	Dec 02 '25	Sale	7.49	2,324	17,402	4,209	Dec 03 09:04 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Dec 02 '25	Sale	7.49	5,720	42,831	80,732	Dec 03 09:04 PM
Nueno Carlos	President, International	Dec 02 '25	Sale	7.49	3,897	29,181	27,175	Dec 03 09:03 PM
Bliss Kelly	President, U.S. Group Health	Dec 02 '25	Sale	7.49	4,582	34,310	60,054	Dec 03 09:03 PM
Rodrigues Fernando M.	Officer	Dec 03 '25	Proposed Sale	7.48	4,209	31,483		Dec 03 09:46 AM
Vandervoort Adam C	Officer	Dec 02 '25	Proposed Sale	7.49	5,720	42,833		Dec 02 04:25 PM
Nueno Carlos	Officer	Dec 02 '25	Proposed Sale	7.49	3,897	29,182		Dec 02 04:22 PM
Bliss Kelly	Officer	Dec 02 '25	Proposed Sale	7.49	4,582	34,311		Dec 02 04:15 PM
Rodrigues Fernando M.	Officer	Dec 02 '25	Proposed Sale	7.49	2,324	17,403		Dec 02 04:14 PM
Paulus Kenneth H	Director	Nov 14 '25	Buy	6.94	10,000	69,400	10,000	Nov 17 04:05 PM
Catapano Joseph Ronald	Chief Accounting Officer	Oct 02 '25	Sale	7.88	2,972	23,434	5,361	Oct 03 04:05 PM
DIVITA CHARLES III	CHIEF EXECUTIVE OFFICER	Sep 11 '25	Sale	7.59	16,787	127,435	179,014	Sep 11 04:04 PM
DIVITA CHARLES III	Officer	Sep 11 '25	Proposed Sale	7.59	16,787	127,435		Sep 11 03:28 PM
Rodrigues Fernando M.	President of BetterHelp	Sep 03 '25	Sale	7.59	4,149	31,491	0	Sep 03 04:05 PM
Rodrigues Fernando M.	President of BetterHelp	Sep 02 '25	Sale	7.58	2,383	18,075	4,149	Sep 03 04:05 PM
Nueno Carlos	President, International	Sep 02 '25	Sale	7.58	3,998	30,325	22,359	Sep 03 04:05 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Sep 02 '25	Sale	7.58	5,867	44,501	75,179	Sep 03 04:05 PM
Bliss Kelly	President, U.S. Group Health	Sep 02 '25	Sale	7.58	4,700	35,650	55,101	Sep 03 04:05 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Sep 02 '25	Sale	7.58	12,846	97,437	142,385	Sep 03 04:05 PM
Rodrigues Fernando M.	Officer	Sep 03 '25	Proposed Sale	7.59	4,149	31,491		Sep 03 11:45 AM
Rodrigues Fernando M.	Officer	Sep 02 '25	Proposed Sale	7.59	2,383	18,076		Sep 02 04:33 PM
Bliss Kelly	Officer	Sep 02 '25	Proposed Sale	7.59	4,700	35,651		Sep 02 04:15 PM
Nueno Carlos	Officer	Sep 02 '25	Proposed Sale	7.59	3,998	30,326		Sep 02 04:09 PM
Vandervoort Adam C	Officer	Sep 02 '25	Proposed Sale	7.59	5,867	44,503		Sep 02 04:05 PM
Murthy Mala	Officer	Sep 02 '25	Proposed Sale	7.59	12,846	97,441		Sep 02 03:59 PM

JAZZ

Jazz Pharmaceuticals plc

PHR

Phreesia Inc

TDOC

Teladoc Health Inc

Upgrade your Finviz experience